No Evidence of a Mild Form of Inhalational Bacillus anthracis Infection During a Bioterrorism-Related Inhalational Anthrax Outbreak in Washington, D.C., in 2001 | Zendy

Henry C. Baggett | Zendy; Julia Rhodes | Zendy; Scott K. Fridkin | Zendy; Conrad P. Quinn | Zendy; Jeffrey Hageman | Zendy; Cindy R. Friedman | Zendy; Clare A. Dykewicz | Zendy; Vera Semenova | Zendy; Sandra RomeroSteiner | Zendy; Cheryl M. Elie | Zendy; John A. Jernigan | Zendy

Open Access

No Evidence of a Mild Form of Inhalational Bacillus anthracis Infection During a Bioterrorism-Related Inhalational Anthrax Outbreak in Washington, D.C., in 2001

Author(s) -

Henry C. Baggett,

Julia Rhodes,

Scott K. Fridkin,

Conrad P. Quinn,

Jeffrey Hageman,

Cindy R. Friedman,

Clare A. Dykewicz,

Vera Semenova,

Sandra RomeroSteiner,

Cheryl M. Elie,

John A. Jernigan

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/432937

Subject(s) - bacillus anthracis , medicine , outbreak , anthrax vaccines , anthrax toxin , serology , antibody , immunology , virology , immunization , biology , bacteria , dna vaccination , biochemistry , genetics , gene , fusion protein , recombinant dna

The mail-related dispersal of Bacillus anthracis spores in the Washington, D.C., area during October 2001 resulted in 5 confirmed cases of inhalational anthrax. We identified an additional 144 ill persons who were potentially exposed to aerosolized spores and whose symptoms were compatible with early inhalational anthrax but whose clinical course and nonserologic laboratory evaluation revealed no evidence for B. anthracis infection. We hypothesized that early antibiotic use could have decreased the sensitivity of diagnostic tests or that bioterrorism-related inhalational anthrax may include mild disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research